Profile data is unavailable for this security.
About the company
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
- Revenue in USD (TTM)15.86m
- Net income in USD-3.23m
- Incorporated2013
- Employees42.00
- LocationCV Sciences Inc9530 PADGETT STREET, SUITE 107SAN DIEGO 92126United StatesUSA
- Fax+1 (619) 876-4321
- Websitehttps://cvsciences.com/
More ▼
Mergers & acquisitions
| Acquired company | CVSI:QBB since announced | Transaction value |
|---|---|---|
| Cultured Foods Sp z o o | 25.25% | 568.00k |
Data delayed at least 15 minutes, as of Jul 26 2024 20:52 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Integrated BioPharma, Inc. | 50.57m | -116.00k | 6.02m | 141.00 | -- | 0.3183 | 28.40 | 0.119 | -0.0041 | -0.0041 | 1.67 | 0.6283 | 1.88 | 4.45 | 10.76 | 358,617.00 | -0.431 | 15.51 | -0.5698 | 27.94 | 7.09 | 12.09 | -0.2294 | 6.44 | 1.02 | -9.00 | 0.001 | -- | -9.91 | 3.00 | -101.35 | -- | -14.03 | -- |
| Sentient Brands Holdings Inc | 0.00 | -818.63k | 6.10m | 2.00 | -- | -- | -- | -- | -0.0145 | -0.0145 | 0.00 | -0.036 | 0.00 | 0.0188 | -- | 0.00 | -317.87 | -220.36 | -- | -- | -- | 41.81 | -- | -31,451.19 | 0.0354 | -2.27 | -- | -- | -73.68 | -- | 34.98 | -- | -- | -- |
| Biofrontera Inc | 33.25m | -23.09m | 6.31m | 85.00 | -- | -- | -- | 0.1898 | -12.47 | -12.47 | 16.84 | -0.3627 | 0.9995 | 2.50 | 5.75 | 391,200.00 | -69.40 | -- | -144.06 | -- | 48.99 | -- | -69.44 | -- | 0.944 | -3.55 | 4.63 | -- | 18.82 | -- | -3,045.47 | -- | -- | -- |
| Sonoma Pharmaceuticals Inc | 12.74m | -4.84m | 6.68m | 172.00 | -- | 0.8934 | -- | 0.5242 | -0.7237 | -0.7237 | 1.40 | 0.3932 | 0.8224 | 2.87 | 4.66 | 74,040.70 | -31.22 | -29.36 | -41.09 | -40.65 | 37.26 | 38.00 | -37.97 | -30.93 | 2.64 | -- | 0.05 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 7.03m | 44.00 | -- | 0.012 | -- | 0.2628 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Cadrenal Therapeutics Inc | 0.00 | -4.85m | 7.15m | 4.00 | -- | 1.16 | -- | -- | -0.3281 | -0.3281 | 0.00 | 0.3868 | 0.00 | -- | -- | 0.00 | -84.07 | -- | -94.36 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.47 | -- | -- | -- |
| Cannapharmarx Inc | 25.84k | -6.61m | 7.29m | 21.00 | -- | -- | -- | 282.02 | -0.0205 | -0.0205 | 0.00008 | -0.0425 | 0.0031 | -- | 0.4503 | 1,230.48 | -79.52 | -131.06 | -- | -- | -1,692.76 | -- | -25,598.30 | -- | 0.0033 | -0.1306 | -- | -- | -- | -- | 143.24 | -- | -- | -- |
| Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.35m | 7.39m | 8.00 | -- | 2.68 | -- | -- | -0.4739 | -0.4739 | 0.00 | 0.1642 | 0.00 | -- | -- | 0.00 | -96.75 | -- | -119.37 | -- | -- | -- | -- | -- | -- | -5.28 | 0.2542 | -- | -- | -- | -112.71 | -- | -- | -- |
| Vestiage Inc | 0.00 | -21.76k | 7.70m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0011 | 0.00 | -- | -- | -- | -4,945.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 7.78m | -- | -- | -- | 5.13 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 8.08m | 233.00 | 0.0542 | 0.0008 | 2.09 | 0.1142 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| CV Sciences Inc | 15.86m | -3.23m | 8.18m | 42.00 | -- | 3.46 | -- | 0.5157 | -0.0207 | -0.0207 | 0.1012 | 0.0145 | 1.59 | 1.42 | 27.25 | 377,571.40 | -32.43 | -43.42 | -83.71 | -77.75 | 45.13 | 51.81 | -20.38 | -45.68 | 0.2677 | -13.32 | 0.0472 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 8.18m | 96.00 | 0.4128 | 0.0682 | 1.49 | 0.2771 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| DH Enchantment Inc | 680.00 | -156.15k | 8.31m | 1.00 | -- | -- | -- | 12,225.15 | -0.0002 | -0.0002 | 0.00 | -0.0012 | 0.0715 | 0.9437 | 45.33 | 680.00 | -1,641.09 | -- | -- | -- | -60.29 | -- | -22,963.23 | -- | 0.0032 | -13.28 | -- | -- | -95.43 | -- | 59.53 | -- | -- | -- |
| Tonix Pharmaceuticals Holding Corp | 10.25m | -98.59m | 9.60m | 103.00 | -- | 0.0117 | -- | 0.9366 | -177.41 | -177.41 | 9.46 | 46.94 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -16.31m | 9.65m | 5.00 | -- | 2.17 | -- | -- | -0.5804 | -0.5804 | 0.00 | 0.1197 | 0.00 | -- | -- | 0.00 | -212.70 | -36.90 | -378.58 | -37.81 | -- | -- | -- | -- | -- | -- | 0.349 | -- | -- | -- | 43.40 | -- | -- | -- |
Data as of Jul 26 2024. Currency figures normalised to CV Sciences Inc's reporting currency: US Dollar USD
0.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| MML Investors Services LLCas of 30 Jun 2024 | 5.00k | 0.00% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
